Bio Details

David Hirsch, MD, PhD

Managing Director, Longitude Capital
Dr. David Hirsch, M.D., Ph.D., has served as a member of our board of directors since July 2016. Dr. Hirsch co-founded Longitude Capital, a healthcare venture capital firm, where he has served as a Managing Director since 2007. Dr. Hirsch currently serves on the board of directors of Poseida Therapeutics, Inc. (PSTX), Molecular Templates, Inc. (MTEM) and Rapid Micro Biosystems, Inc. (RPID). In addition, Dr. Hirsch serves on the board of directors of Alpha-9 Theranostics Inc., a private company for which he is also serving as the interim CEO. Dr. Hirsch previously served on the boards of directors of multiple other companies, including Collegium Pharmaceutical, Inc. (COLL). Dr. Hirsch holds a Ph.D. in Biology from the Massachusetts Institute of Technology, an M.D. from Harvard Medical School and a B.A. in Biology from Johns Hopkins University.